Results 291 to 300 of about 22,609,350 (346)

Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy. [PDF]

Int J Mol Sci
Baldini L, Del Vecchio L, Cerasi S, Fetta A, Moratti M, Bezzi A, Ferrari S, Di Dalmazi G, Rossi S, Toni F, Cordelli DM, Lanari M, Conti F.   +12 more
europepmc   +1 more source

Atypical Melanosis on Acral Skin or Early Acral Lentiginous Melanoma? Reappraising an Ambiguous Concept in Acquired Acral Pigmented Lesions

Journal of Cutaneous Pathology, Volume 53, Issue 7, Page 648-654, July 2026.
Marcial Álvarez‐Salafranca, Pedro Gil‐Pallares, Alba Navarro‐Bielsa, Tamara Gracia‐Cazaña, Carlos Monteagudo, María Carmen Gómez‐Mateo   +5 more
wiley   +1 more source

DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix. [PDF]

J Immunother Cancer
Chae YK, Othus M, Patel SP, Backes FJ, O'Malley DM, Cristea M, Naing A, Kurnit K, Eskander RN, T Goodrich S, Robinson WR, Scalici J, Chan J, Ali-Ahmad H, Hays J, McCormick C, Kim EJ, Sueblinvong T, Ahmed A, Siedel J, Thomes Pepin J, Bottsford-Miller JN, Fagbemi SO, Jaslowski AJ, Kim HS, Chung LI, Moloney-Lineen C, McLeod CM, Chen HX, Sharon E, Streicher H, Ryan CW, Blanke CD, Kurzrock R.   +33 more
europepmc   +1 more source

Erratum to: Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma. [PDF]

Neuro Oncol
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells

Immunity
RNA splicing is involved in cancer initiation and progression, but how it influences host antitumor immunity in the metabolically abnormal tumor microenvironment (TME) remains unclear.
Qiaoqiao Han
exaly   +2 more sources

CTLA-4 and T cell activation

Current Opinion in Immunology, 1999
The past year has seen significant advances in our understanding of the role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in regulating T cell activation and tolerance. Recent studies indicate that CTLA-4 not only counterbalances CD28 signals but also can inhibit T cell responses independently of CD28. Recent work has also revealed a role for CTLA-4 in
Didier A Mandelbrot, Robert B Lorsbach, Arlene H Sharpe   +2 more
exaly   +3 more sources